Cortexin vs P21 (Adamax)

A side-by-side comparison from PeptideSciences101, the open peptide reference.

Overview

Cortexin and P21 (Adamax) are both cognitive enhancement peptides, but they differ in mechanism, dosing, and regulatory status.

This page compares Cortexin and P21 (Adamax) across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

CortexinP21 (Adamax)
CategoryCognitive EnhancementCognitive Enhancement
Regulatory status (US)Research use onlyResearch use only
Typical dosage10 mg5-20 mg
Frequencydaily for cyclesintermittent
Reported benefitsNeuroprotection, cognitive enhancement, recovery supportEnhanced learning, neuroplasticity, memory formation
Reported side effectsGenerally well-toleratedResearch compound, limited data

Key differences

Primary use. Cortexin is categorised under Cognitive Enhancement, while P21 (Adamax) falls under Cognitive Enhancement. Because they target a similar goal, they are common alternatives to weigh against each other.

Regulatory status. Cortexin: not FDA-approved; treated as a research compound. P21 (Adamax): not FDA-approved; treated as a research compound.

Dosing. Cortexin is typically dosed at 10 mg (daily for cycles). P21 (Adamax) is typically dosed at 5-20 mg (intermittent).

Can you stack them?

Some protocols combine peptides, but stacking Cortexin and P21 (Adamax) has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between Cortexin and P21 (Adamax)?
Cortexin and P21 (Adamax) are both cognitive enhancement peptides, but they differ in mechanism, dosing, and regulatory status. Cortexin is not FDA-approved; generally classified as a research compound, whereas P21 (Adamax) is not FDA-approved; generally classified as a research compound.
What is Cortexin used for?
Neuropeptide complex.
What is P21 (Adamax) used for?
Neurogenic peptide.
Can you take Cortexin and P21 (Adamax) together?
Some users combine peptides within a single protocol, but stacking Cortexin and P21 (Adamax) has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
Is Cortexin or P21 (Adamax) FDA-approved?
Cortexin is not FDA-approved; generally classified as a research compound. P21 (Adamax) is not FDA-approved; generally classified as a research compound.

Read the full articles

  • Cortexin — full monograph: mechanism, research, dosing & references
  • P21 (Adamax) — full monograph: mechanism, research, dosing & references

More Cognitive Enhancement comparisons

← All peptide comparisons